Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01775436 · ClinicalTrials.gov registry record · NA

Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care

A NA study of HIV, sponsored by Children's National Research Institute.

Completed
Registry status
NA
Development phase
444
Enrollment target
5
Study locations

NCT01775436 is a NA study of HIV that has completed, run by Children's National Research Institute. The registered enrollment target is 444 participants, roughly in line with the 438-participant average among 303 other HIV trials with a reported enrollment target. The trial reports 5 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01775436, a NA study of HIV, has completed, sponsored by Children's National Research Institute.

COMPLETED
Registry status
NA
Development phase
444 participants
Enrollment target
5
Study locations

Study Summary

Our goal is to advance palliative care with persons living with AIDS (PLWA) or life-limiting co-morbidities to decrease suffering and increase quality of life (QOL). Left without advance care planning (ACP) for end-of-life decision, miscommunication and disagreements may result in families being charged with neglect or court battles over treatment choices, unmet care or delivery of unnecessary or unwanted care, and non-relative caregivers being dismissed (e.g. gay partners). We hope to increase families' understandings of their family member's wishes for end-of-life care to decrease conflict through the FAmily-CEntered Advance (FACE) Care Planning intervention. We will also study communication, quality of life, and spiritual struggle. Families will be randomized into either the Control (N=96 families) or the FACE Intervention (n=192 dyads). FACE families will meet with a trained/certified researcher for two 60-minute sessions scheduled one week apart: Session 1: The Respecting Choices Interview®; and Session 2: Completion of The Five Wishes©. Control families will also meet with a researcher for two 60-minute sessions scheduled one week apart: Session 1: Developmental History; and Session 2: Nutrition and Exercise. Questionnaires will be administered five times, Baseline and at 3, 6, 12 and 18 month post-intervention, for an average of 2 years. AIM 1. To determine the efficacy of FACE on congruence in treatment preferences between PLWA and their surrogates over time, and the effect of the pattern of congruence development trajectory on healthcare utilization (i.e., distal outcomes: number of hospitalizations, dialysis, ER visits). Hypothesis A: Development of congruence may not be homogeneous and FACE may influence the pattern of congruence development. Hypothesis B: Different patterns of congruence development may have different effects on health care utilization. Hypothesis C: Compared to Controls, FACE participants will better maintain congruence over time.

Conditions Studied

Interventions

  • BEHAVIORAL FAmily-CEntered Advance Care Planning
  • BEHAVIORAL Healthy Living Control

Study Locations (5)

District of Columbia

  • Georgetown University Hospital - Washington D.C.
  • Children's National Medical Center - Washington D.C.
  • Institute for Clinical Research, Inc. (Affiliated with Department of Veterans Affairs Medical Center of Washington, DC) - Washington D.C.
  • MedStar Health Research Institute/Washington Hospital Center - Washington D.C.
  • George Washington University - Washington D.C.

Trial Details

FieldValue
Enrollment Target 444 participants
Start Date 2013-10-13
Est. Completion 2017-03-28
Phase NA

What the Registry Record Tells You About NCT01775436

The ClinicalTrials.gov registry entry for NCT01775436 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 444 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 438-participant average among 303 other HIV trials with a reported enrollment target. The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which FAmily-CEntered Advance Care Planning is the first listed.

NCT01775436 reports 5 study locations spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT01775436 about?

NCT01775436 is a clinical study titled "Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care". Our goal is to advance palliative care with persons living with AIDS (PLWA) or life-limiting co-morbidities to decrease suffering and increase quality of life (QOL). Left without advance care planning (ACP) for end-of-life decision, miscommunication and disagreements may result in families being cha...

What is the current status of trial NCT01775436?

This trial is currently completed. It is a NA study. The enrollment target is 444 participants. The study started on 2013-10-13. Estimated completion is 2017-03-28.

What conditions does trial NCT01775436 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT01775436?

The interventions under investigation include: FAmily-CEntered Advance Care Planning (BEHAVIORAL), Healthy Living Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT01775436?

This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01775436 being conducted?

This trial has 5 study locations across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.